Beryl Capital Management LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 11:23 am Sale | 2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Beryl Capital Management LLC | 0 0.000% | -9,667 (Position Closed) | Filing |
| 2022-02-14 2:50 pm Purchase | 2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Beryl Capital Management LLC | 9,667 5.000% | 9,667 (New Position) | Filing |